We specialize in hard to find items
(1)
Characterization of dihydroorotate dehydrogenase for malaria therapy: Production,purification and co-crystallization of Plasmodium falciparum and Plasmodium vivax DHODH with novel inhibitors
Share Tweet
*Price and Stocks may change without prior notice
*Packaging of actual item may differ from photo shown
- Electrical items MAY be 110 volts.
- 7 Day Return Policy
- All products are genuine and original
- Cash On Delivery/Cash Upon Pickup Available
About Characterization Of Dihydroorotate Dehydrogenase
Malaria remains a world's disease burden causing high incidences of mortality in susceptible populations.Severe cases of malaria are caused by parasites of the apicomplexan Plasmodium falciparum localized in sub-saharan Africa whereas less severe malaria but most prevalent outside Africa is caused by Plasmodium vivax.Malaria campaigns through vector control and effective artemesinins-based combination therapy has considerably reduced malarial mortality ratesin the past decade.However, increasing cases of drug resistance has raised an urgent need for development of new anti-malarial drugs. In-silico drug design using the structure of the biological target is the latest lead optimization option in search of more potent drugs.In this work, i sought to determine the 3-dimensional structure of the biological target,dehydroorotate dihydrogenase(DHODH) from the above mentioned plasmodia species co-crystallized with novel drug candidates.Characterization of the parasitic DHODH involved target gene cloning,site directed mutagenesis,protein expression and purification and subsequent co-crystallization for structure determination.This book therefore,targets life science research professionals
